Your browser doesn't support javascript.
loading
Targeted amplification and genetic sequencing of the severe acute respiratory syndrome coronavirus 2 surface glycoprotein.
Keller, Matthew W; Keong, Lisa M; Rambo-Martin, Benjamin L; Hassell, Norman; Lacek, Kristine A; Wilson, Malania M; Kirby, Marie K; Liddell, Jimma; Owuor, D Collins; Sheth, Mili; Madden, Joseph; Lee, Justin S; Kondor, Rebecca J; Wentworth, David E; Barnes, John R.
Afiliación
  • Keller MW; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Keong LM; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Rambo-Martin BL; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Hassell N; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Lacek KA; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Wilson MM; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Kirby MK; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Liddell J; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Owuor DC; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Sheth M; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
  • Madden J; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
  • Lee JS; Biotechnology Core Facility Branch, Division of Scientific Resources, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention , Atlanta, Georgia, USA.
  • Kondor RJ; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Wentworth DE; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
  • Barnes JR; Influenza Division, National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC) , Atlanta, Georgia, USA.
Microbiol Spectr ; 12(1): e0298223, 2024 Jan 11.
Article en En | MEDLINE | ID: mdl-38084972
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Humans Idioma: En Revista: Microbiol Spectr Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Vacunas / COVID-19 Límite: Humans Idioma: En Revista: Microbiol Spectr Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos